Sociedad Química y Minera de Chile S.A. (SQM) | The Buildout — AI Infrastructure
The Verdict
SQM produces lithium chemicals used in electric vehicle and energy storage batteries, iodine for medical and industrial applications, and specialty fertilizers. Its business is not directly tied to AI infrastructure, but its lithium is an essential material for the broader electrification trend that supports data center backup and grid storage.
| Market Cap | — |
| Revenue (TTM) | $5.3B |
| Revenue Growth | +18.5% |
| EBITDA Margin (TTM) | 34.0% |
| Net Debt | $1.3B |
| Earnings Beats | 0 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Lithium volume guided up 11% for 2026 to ~260,000 LCE, with 80% already contracted — locking in revenue visibility.
- Iodine contributed 42% of total gross margin in 2025, providing a high-margin buffer outside lithium.
- Codelco JV secures Salar de Atacama brine rights through 2060, eliminating binary license risk.
- Capital discipline: $2.7B three-year plan (down 22%) without sacrificing volume growth, via efficiency gains and sulfate-route flexibility.
- Q4 lithium volumes >66,000 mt (+50% YoY) and management calling an inflection point in prices, supported by ESS demand up 40–50%.
What We’re Watching
- Kwinana refinery ramp-up delayed to 2027; resolution expected mid-2026 — any further slips would keep Australian output in lower-margin spodumene.
- Iodine competitor projects expected H2 2026 could erode record prices and the 42% margin contribution.
- Salar Futuro environmental permit submission mid-2026, but final decision not until 2029–2030; denial would halt extraction post-2030.
- Tianqi’s ongoing share sales create an overhang; SQM cannot buy back shares under Chilean law.
The business thesis is strengthening as lithium prices recover and volumes grow, with iodine providing a profit buffer. However, SQM’s lack of AI exposure limits its direct relevance to the buildout narrative. The key open question is whether energy storage demand eventually connects to data centers and whether the Salar Futuro permit is secured post-2030.
Earnings
Q4 FY2025 revenue rose to $1.34 billion, with gross margin of 34.1% and EBITDA of $514 million. Lithium sales volumes exceeded 66,000 metric tons, up over 50% year-over-year, while average realized lithium prices climbed nearly 14% sequentially to approximately $10/kg.
| Metric | Q1 FY2026 | Q4 FY2025 | Q1 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $1.8B | $1.3B | $1.0B | +69.8% |
| Gross margin | 44.2% | 34.1% | 29.4% | +1480bps |
| EBITDA | $836M | $514M | $246M | +239.2% |
| EPS | $1.28 | $0.65 | $0.48 | +165.9% |
| Lithium sales volume (mt) | >66,000 | n/a | ~44,000 | +50% |
our sales price in Q1, I can say now that will be substantially higher than Q4 2025. That is one very good news.— Felipe Smith, Commercial VP, Nova Andino Litio, 2 March 2026
Management tone: Management’s tone on lithium pricing shifted from cautiously optimistic in prior quarters to calling an inflection point, forecasting substantially higher Q1 2026 prices and guiding that full-year prices should be closer to current levels than 2025’s trough.
Management Guidance
Management guided 2026 lithium production of approximately 260,000 LCE and expects Q1 sales volume to be more than 15% higher year-over-year with prices substantially above Q4’s ~$10/kg. Full-year lithium prices are expected closer to current levels than 2025’s trough. Iodine volumes are seen stable to slightly higher, while SPN volume growth is forecast at 2–4%. The Kwinana hydroxide refinery ramp-up was moved into 2027.
Trajectory
Revenue rebounded from a mid-2025 low, reaching $1.76 billion in Q1 FY2026. Gross margins widened from 24.3% in Q2 FY2025 to 44.2% in Q1 FY2026, driven by recovering lithium prices and record iodine profitability. Lithium sales volumes surged over 50% YoY in Q4, and management guided for Q1 volumes to hit a new quarterly record.
The Model
No projection published for this company. No model projection is available for this company.
The model publishes revenue and EBITDA projections only where the evidence supports them. Where it does not, nothing is shown rather than an estimate.
Looking Ahead
The next twelve months pivot on mid-2026 decisions: the Mt Holland expansion FID and Salar Futuro environmental submission. Q1 2026 results will test management’s bold pricing call, and the Kwinana odour fix announcement will clarify the hydroxide timeline. New iodine supply from competitors is expected in H2, potentially testing the durability of record margins.
- April 2026First Codelco dividend payment — Cash outflow on 33,500 mt of lithium profit attributed to Codelco.
- Mid-2026Mt Holland expansion FID — Board decision; ~$200M already in 2027 CapEx plan.
- Mid-2026Salar Futuro environmental submission — Filing for post-2030 extraction permit; final decision years away.
- Mid-2026Kwinana odour fix announcement — If resolved, full hydroxide ramp proceeds through 2027.
- H2 2026Competitor iodine projects start — New supply could test record iodine prices and SQM’s margin buffer.
Financials
Annual Summary
| Metric | FY2025 | TTM |
|---|---|---|
| Revenue | $4.6B | $5.3B |
| Gross Margin | 29.3% | 34.5% |
| EBITDA | $1.2B | $2.8B |
| EBITDA Margin | 26.6% | 34.0% |
| Net Income | $590M | $817M |
| Free Cash Flow | $438M | $1.4B |
| Net Cash | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)34.5%
- EBITDA Margin (TTM)34.0%
- Net Margin (TTM)15.4%
- ROIC17.4%
- FCF Conversion59.7%
- SBC / Revenue0.0%
The Company
SQM is a diversified producer of lithium, iodine, and specialty plant nutrition products. It describes itself as the world’s largest producer of potassium nitrate and iodine, and one of the world’s largest lithium producers. In 2025, 96.5% of its sales came from outside Chile.
The company operates brine extraction at the Salar de Atacama through its Nova Andino Litio joint venture with Codelco, hard-rock spodumene mining at Mount Holland in Western Australia via a 50/50 JV with Wesfarmers, and chemical conversion plants in Chile, China, and Australia. Iodine is extracted from caliche deposits in Chile, and potassium nitrate is produced at its Coya Sur plant.
Business Segments
Competitive Landscape
In lithium, SQM competes with Albemarle, Ganfeng, and Tianqi, holding a low-cost brine position. The company acknowledges its carbonate-heavy mix may discount to hydroxide indices, but its sulfate-to-China conversion path provides a cost advantage over Western hard-rock converters. In iodine, it is the market leader facing new supply from Chilean competitors.
- AlbemarleNamed in 20‑F with 12% lithium market share. Albemarle’s Q1 2026 ASP of ~$17/kg and DLE permitting at Salar de Atacama signal competitive pricing and technology threats.
- Jiangxi Ganfeng Lithium CoNamed in 20‑F with 6% lithium market share. Not discussed in detail.
- Tianqi Lithium CorpNamed in 20‑F with 5% lithium market share. Tianqi is also an active seller of SQM shares, creating an overhang.
- S.C.M. CosayachNamed in 20‑F as iodine competitor. Not discussed in detail.
- Haifa ChemicalsNamed in 20‑F as SPN/industrial chemicals competitor. Not discussed in detail.
Supply Chain
SQM sits at the extraction and processing stage, supplying lithium to battery cathode producers and iodine to medical/industrial users. No AI infrastructure supply chain neighbor mentions SQM by name.
More on SQM: Earnings preview